相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint
Monika Biniecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Synovial tissue hypoxia and inflammation in vivo
C. T. Ng et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Hypoxia-Inducible Factor-1 as Regulator of Angiogenesis in Rheumatoid Arthritis - Therapeutic Implications
J. Westra et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis
Daitaro Kurosaka et al.
JOURNAL OF RHEUMATOLOGY (2010)
Quantitative Power Doppler Ultrasonography Is a Sensitive Measure of Metacarpophalangeal Joint Synovial Vascularity in Rheumatoid Arthritis and Declines Significantly Following a 2-week Course of Oral Low-dose Corticosteroids
Maggie J. Larche et al.
JOURNAL OF RHEUMATOLOGY (2010)
Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
Shenhong Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Regulation of the Angiopoietin-Tie ligand-receptor system with a novel splice variant of Tie1 reduces the severity of murine arthritis
Nasser M. Malik et al.
RHEUMATOLOGY (2010)
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study
Tuulikki Sokka et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients
Thierry Bege et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
T. Bongartz et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
Hypoxia-inducible factor 1α is deregulated by the serum of rats with adjuvant-induced arthritis
Hye-Lim Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Inhibition of HIF-1α activity by BP-1 ameliorates adjuvant induced arthritis in rats
J. Shankar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model
Ken Matsumoto et al.
CANCER SCIENCE (2009)
A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases
Pal Soltesz et al.
CLINICAL RHEUMATOLOGY (2009)
A pan-HER approach for cancer therapy: background, current status and future development
Zhongdong Huang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
The vasculature in rheumatoid arthritis: cause or consequence?
Ewa M. Paleolog
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis
Daitaro Kurosaka et al.
MODERN RHEUMATOLOGY (2009)
Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
Sanjaykumar Hapani et al.
LANCET ONCOLOGY (2009)
Adverse effects of anticancer agents that target the VEGF pathway
Helen X. Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Gregg L. Semenza
PHYSIOLOGY (2009)
Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
Elena Izquierdo et al.
PLOS ONE (2009)
Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation
Carol A. Hitchon et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis
Mohammed A. Akhavani et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Antagonism of the Human Epidermal Growth Factor Receptor Family Controls Disease Severity in Murine Collagen-Induced Arthritis
Percy F. Sumariwalla et al.
ARTHRITIS AND RHEUMATISM (2008)
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study
Zurab Nadareishvili et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients
Hilal Maradit Kremers et al.
ARTHRITIS AND RHEUMATISM (2008)
Targeted therapies in breast cancer: Where are we now?
Serena Di Cosimo et al.
EUROPEAN JOURNAL OF CANCER (2008)
The specific contribution of hypoxia-inducible factor-2α to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors
Christina Warnecke et al.
EXPERIMENTAL CELL RESEARCH (2008)
Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts
H. Manabe et al.
INFLAMMATION RESEARCH (2008)
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients A Meta-analysis
Shobha Rani Nalluri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: Results of the TREE study
Howard S. Hochster et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis
Branavan Sivakumar et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2008)
Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients
Shoji Yamane et al.
JOURNAL OF INFLAMMATION-LONDON (2008)
An Angiogenesis Inhibitor, 2-Methoxyestradiol, Involutes Rat Collagen-Induced Arthritis and Suppresses Gene Expression of Synovial Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor
Ernest Brahn et al.
JOURNAL OF RHEUMATOLOGY (2008)
Spontaneous, delayed colon and rectal anastomotic complications associated with revacizumab therapy
David A. August et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of hypoxia-inducible factor-1α in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes
J. K. Ahn et al.
RHEUMATOLOGY (2008)
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
Pei Jin et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Targeting Angiogenesis in Rheumatoid Arthritis
Zoltan Szekanecz et al.
CURRENT RHEUMATOLOGY REVIEWS (2008)
Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients
Yeon-Ah Lee et al.
CLINICAL RHEUMATOLOGY (2007)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
Richard O. Williams et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition
John Bainbridge et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Vascular endothelial growth factor: Biology and therapeutic applications
Quoc T. Ho et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Patterns of cardiovascular risk in rheumatoid arthritis
D. H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1α and inhibits angiogenesis
Ken Matsumoto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis
S. Van Doornum et al.
ARTHRITIS AND RHEUMATISM (2006)
Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway
Veronica A. Carroll et al.
CANCER RESEARCH (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis
A Kuryliszyn-Moskal et al.
CLINICAL RHEUMATOLOGY (2006)
Cardiovascular disease in rheumatoid arthritis
Mariana J. Kaplan
CURRENT OPINION IN RHEUMATOLOGY (2006)
Targeting the EGFR pathway for cancer therapy
James B. Johnston et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Rheumatoid arthritis: A disease associated with accelerated atherogenesis
MA Gonzalez-Gay et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Addition of bevacizurnab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
TGF-α and ErbB2 production in synovial joint tissue:: increased expression in arthritic joints
AL Hallbeck et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
Angiogenesis in rheumatoid arthritis
Z Szekanecz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction
Y Chen et al.
ARTHRITIS AND RHEUMATISM (2005)
Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
LM Hermann et al.
CLINICAL IMMUNOLOGY (2005)
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer
KD Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis
PC Taylor et al.
ARTHRITIS AND RHEUMATISM (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Death rates and causes of death in patients with rheumatoid arthritis: a population-based study
S Sihvonen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The transcription factors hypoxia-inducible factor 1 alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis
CL Peters et al.
ARTHRITIS AND RHEUMATISM (2004)
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis
M De Bandt et al.
JOURNAL OF IMMUNOLOGY (2003)
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
AO Afuwape et al.
GENE THERAPY (2003)
Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α-induced angiogenesis in rheumatoid arthritis
LM DeBusk et al.
ARTHRITIS AND RHEUMATISM (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
YGI: A potential anticancer drug targeting hypoxia-inducible factor 1
EJ Yeo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
Hypoxia induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis
DP Naughton
MEDICAL HYPOTHESES (2003)
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α
EM Gravallese et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Upregulated hypoxia inducible factor-1 alpha and -2 alpha pathway in rheumatoid arthritis and osteoarthritis
A Giatromanolaki et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis
S Thornton et al.
CLINICAL IMMUNOLOGY (2002)
Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts
C Hitchon et al.
ARTHRITIS AND RHEUMATISM (2002)
Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue
S Shahrara et al.
ARTHRITIS RESEARCH (2002)
Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis - Correlation with disease activity
H Sone et al.
LIFE SCIENCES (2001)
The angiogenic pathway 'vascular endothelial growth factor/flk-I (KDR)-receptor' in rheumatoid arthritis and osteoarthritis
A Giatromanolaki et al.
JOURNAL OF PATHOLOGY (2001)
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
H Sone et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study
EM Barrett et al.
RHEUMATOLOGY (2000)
Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation
T Uchida et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
J Miotla et al.
LABORATORY INVESTIGATION (2000)
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
J Lu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
